All In Biotech

Drug Trial Radar · NCT07468513

Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

Last checked: Nov 20, 2026Latest source record: Mar 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

May 17, 2024

Primary completion

Jun 30, 2028

Study completion Dec 31, 2028

Sponsor

Lead sponsor
Menzies School of Health ResearchAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Curtin University; University of Melbourne; Arba Minch University; Papua New Guinea Institute of Medical Research; Mahidol Oxford Tropical Medicine Research Unit; Oxford University Clinical Research Unit, Vietnam; Universitas Indonesia
First posted
Mar 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A non randomized observation study that is aiming to assess the safety and efficacy of high dose primaquine (1mg/kg per day over 7 days) among patients with intermediate (30-70%) G6PD activity and the safety and efficacy of weekly primaquine among patients who are g6Pd deficient (\<30% activity)

Conditions

  • Vivax Malaria
  • G6PD Deficiency

Interventions

  • Patients with G6PD enzyme activities between 30 and <70% of the AMM will be treated with schizontocidal treatment plus high dose primaquine 1mg/kg/day for 7 daysDrug

    Primaquine 1mg/kg/day for 7 days

  • Patients with G6PD enzyme activities <30% of the AMM will be treated with schizontocidal treatment plus 8 weekly primaquine (0.75mg/kg dose).Drug

    8 weekly Primaquine (0.75mg/kg dose).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and efficacy of high dose primaquineTime frame: 6 Months

Locations

4 sites in 3 countries. Site status is shown where the registry gives one.

  • Dr Marcus Lacerda

    Manaus, Brazil · Recruiting

  • Arba Minch General Hospital

    Arba Minch, Ethiopia · Not yet recruiting

  • Dr Moses Laman and Dr Brioni Moore

    Alexishafen, Madang Province, Papua New Guinea · Recruiting

  • Papua New Guinea Institute of Medical Research

    Port Moresby, Magang, Papua New Guinea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.